Hepatology International

, Volume 8, Supplement 2, pp 439–446 | Cite as

Immunity and inflammatory signaling in alcoholic liver disease

Supplement Issue: ALPD


The pathogenesis of alcoholic liver disease (ALD) is multifactorial and characterized by steatosis, steatohepatitis and cirrhosis. Several signaling pathways in different liver cell types that contribute to the development and progression of alcoholic liver injury have been identified. Among these, immune cells and signaling pathways are the most prominent and central to ALD. Both innate and adaptive immune responses contribute to ALD. The key features of inflammatory pathways in ALD including liver innate and adaptive immune cell types, signaling receptors/pathways, and pro- and antiinflammatory/protective responses are summarized here.


ALD ASH Hepatic inflammation PRRs Cytokines Immunity 


  1. 1.
    Singal AK, Anand BS. Recent trends in the epidemiology of alcoholic liver disease. Clin Liver Dis 2013;2:53–56CrossRefGoogle Scholar
  2. 2.
    Mandrekar P, Szabo G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol 2009;50:1258–1266PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005;17:1–14PubMedCrossRefGoogle Scholar
  4. 4.
    Thurman RG, Bradford BU, Iimuro Y, Frankenberg MV, Knecht KT, Connor HD et al. Mechanisms of alcohol-induced hepatotoxicity: studies in rats. Front Biosci 1999;4:e42–e46Google Scholar
  5. 5.
    Szabo G, Dolganiuc A, Mandrekar P. Pattern recognition receptors: a contemporary view on liver diseases. Hepatology 2006;44:287–298PubMedCrossRefGoogle Scholar
  6. 6.
    Hritz I, Mandrekar P, Velayudham A, Catalano D, Dolganiuc A, Kodys K, et al. The critical role of Toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 2008;48:1224–1231PubMedCrossRefGoogle Scholar
  7. 7.
    Inokuchi S, Tsukamoto H, Park E, Liu ZX, Brenner DA, Seki E. Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcohol Clin Exp Res 2011;35:1509–1518PubMedPubMedCentralGoogle Scholar
  8. 8.
    Thakur V, Pritchard MT, McMullen MR, Wang Q, Nagy LE. Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J Leukoc Biol 2006;79:1348–1356PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Mandal P, Pratt BT, Barnes M, McMullen MR, Nagy LE. Molecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin. J Biol Chem 2011;286:13460–13469PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Wan J, Benkdane M, Teixeira-Clerc F, Bonnafous S, Louvet A, Lafdil F, et al. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and non-alcoholic fatty liver disease. Hepatology 2013;59:130–142PubMedCrossRefGoogle Scholar
  11. 11.
    Dalakas E, Newsome PN, Boyle S, Brown R, Pryde A, McCall S, et al. Bone marrow stem cells contribute to alcohol liver fibrosis in humans. Stem Cells Dev 2010;19:1417–1425PubMedCrossRefGoogle Scholar
  12. 12.
    Bosma BM, Metselaar HJ, Mancham S, Boor PP, Kusters JG, Kazemier G, et al. Characterization of human liver dendritic cells in liver grafts and perfusates. Liver Transplant 2006;12:384–393CrossRefGoogle Scholar
  13. 13.
    Yoneyama H, Ichida T. Recruitment of dendritic cells to pathological niches in inflamed liver. Med Mol Morphol 2005;38:136–141PubMedCrossRefGoogle Scholar
  14. 14.
    Feng D, Eken A, Ortiz V, Wands JR. Chronic alcohol-induced liver disease inhibits dendritic cell function. Liver Int 2011;31:950–963PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Jaeschke H. Neutrophil-mediated tissue injury in alcoholic hepatitis. Alcohol 2002;27:23–27PubMedCrossRefGoogle Scholar
  16. 16.
    Miyamoto M, Prause O, Sjostrand M, Laan M, Lotvall J, Linden A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 2003;170:4665–4672PubMedCrossRefGoogle Scholar
  17. 17.
    Ramaiah SK, Jaeschke H. Hepatic neutrophil infiltration in the pathogenesis of alcohol-induced liver injury. Toxicol Mech Methods 2007;17:431–440PubMedCrossRefGoogle Scholar
  18. 18.
    Tritto G, Bechlis Z, Stadlbauer V, Davies N, Frances R, Shah N, et al. Evidence of neutrophil functional defect despite inflammation in stable cirrhosis. J Hepatol 2011;55:574–581PubMedCrossRefGoogle Scholar
  19. 19.
    Stadlbauer V, Mookerjee RP, Wright GA, Davies NA, Jurgens G, Hallstrom S, et al. Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 2009;296:G15–G22PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Bertola A, Park O, Gao B. Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury: A critical role for E-selectin. Hepatology 2013;9(9):1132–1140Google Scholar
  21. 21.
    Jeong WI, Park O, Gao B. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 2008;134:248–258PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Zhang H, Meadows GG. Exogenous IL-15 in combination with IL-15R alpha rescues natural killer cells from apoptosis induced by chronic alcohol consumption. Alcohol Clin Exp Res 2009;33:419–427PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol 2009;86:513–528PubMedPubMedCentralGoogle Scholar
  24. 24.
    Minagawa M, Deng Q, Liu ZX, Tsukamoto H, Dennert G. Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-alpha during alcohol consumption. Gastroenterology 2004;126:1387–1399PubMedCrossRefGoogle Scholar
  25. 25.
    Thiele GM, Freeman TL, Klassen LW. Immunologic mechanisms of alcoholic liver injury. Semin Liver Dis 2004;24:273–287PubMedCrossRefGoogle Scholar
  26. 26.
    Thiele GM, Duryee MJ, Willis MS, Tuma DJ, Radio SJ Hunter CD, et al. Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites. Alcohol Clin Exp Res 2010;34:2126–2136PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Rolla R, Vay D, Mottaran E, Parodi M, Traverso N, Arico S, et al. Detection of circulating antibodies against malondialdehyde–acetaldehyde adducts in patients with alcohol-induced liver disease. Hepatology 2000;31:878–884PubMedCrossRefGoogle Scholar
  28. 28.
    Lemmers A, Moreno C, Gustot T, Marechal R, Degre D, Demetter P, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 2009;49:646–657PubMedCrossRefGoogle Scholar
  29. 29.
    Uesugi T, Froh M, Arteel GE, Bradford BU, Thurman RG. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 2001;34:101–108PubMedCrossRefGoogle Scholar
  30. 30.
    Muralidharan S, Mandrekar P. Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation. J Leukoc Biol 2013;94(6):1167–1184PubMedCrossRefGoogle Scholar
  31. 31.
    Gustot T, Lemmers A, Moreno C, Nagy N, Quertinmont E, Nicaise C, et al. Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 2006;43:989–1000PubMedCrossRefGoogle Scholar
  32. 32.
    Mandrekar P, Catalano D, Jeliazkova V, Kodys K. Alcohol exposure regulates heat shock transcription factor binding and heat shock proteins 70 and 90 in monocytes and macrophages: implication for TNF-alpha regulation. J Leukoc Biol 2008;84:1335–1345PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    McVicker BL, Tuma DJ, Kharbanda KK, Kubik JL, Casey CA. Effect of chronic ethanol administration on the in vitro production of proinflammatory cytokines by rat Kupffer cells in the presence of apoptotic cells. Alcohol Clin Exp Res 2007;31:122–129PubMedCrossRefGoogle Scholar
  34. 34.
    Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 2012;122:3476–3489PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Byun JS, Suh YG, Yi HS, Lee YS, Jeong WI. Activation of Toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice. J Hepatol 2013;58:342–349PubMedCrossRefGoogle Scholar
  36. 36.
    Kishore R, Hill JR, McMullen MR, Frenkel J, Nagy LE. ERK1/2 and Egr-1 contribute to increased TNF-alpha production in rat Kupffer cells after chronic ethanol feeding. Am J Physiol Gastrointest Liver Physiol 2002;282:G6–G15PubMedGoogle Scholar
  37. 37.
    Shi L, Kishore R, McMullen MR, Nagy LE. Chronic ethanol increases lipopolysaccharide-stimulated Egr-1 expression in RAW 264.7 macrophages: contribution to enhanced tumor necrosis factor alpha production. J Biol Chem 2002;277:14777–14785PubMedGoogle Scholar
  38. 38.
    Kishore R, McMullen MR, Nagy LE. Stabilization of tumor necrosis factor alpha mRNA by chronic ethanol: role of A+U-rich elements and p38 mitogen-activated protein kinase signaling pathway. J Biol Chem 2001;276:41930–1937PubMedCrossRefGoogle Scholar
  39. 39.
    Mandrekar P, Bala S, Catalano D, Kodys K, Szabo G. The opposite effects of acute and chronic alcohol on lipopolysaccharide-induced inflammation are linked to IRAK-M in human monocytes. J Immunol 2009;183:1320–1227PubMedCrossRefGoogle Scholar
  40. 40.
    Zhao XJ, Dong Q, Bindas J, Piganelli JD, Magill A, Reiser J, et al. TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. J Immunol 2008;181:3049–3056PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Crabb DW, Galli A, Fischer M, You M. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. Alcohol 2004;34:35–38PubMedCrossRefGoogle Scholar
  42. 42.
    Horiguchi N, Wang L, Mukhopadhyay P, Park O, Jeong WI, Lafdil F, et al. Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology 2008;134:1148–1158PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Miller AM, Wang H, Park O, Horiguchi N, Lafdil F, Mukhopadhyay P, et al. Anti-inflammatory and anti-apoptotic roles of endothelial cell STAT3 in alcoholic liver injury. Alcohol Clin Exp Res 2010;34:719–725PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Menon KV, Stadheim L, Kamath PS, Wiesner RH, Gores GJ, Peine CJ, et al. A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol 2004;99:255–260PubMedCrossRefGoogle Scholar
  45. 45.
    Olleros ML, Martin ML, Vesin D, Fotio AL, Santiago-Raber ML, Rubbia-Brandt L, et al. Fat diet and alcohol-induced steatohepatitis after LPS challenge in mice: role of bioactive TNF and Th1 type cytokines. Cytokine 2008;44:118–125PubMedCrossRefGoogle Scholar
  46. 46.
    Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology 2011;54:2185–2197PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Barnes MA, McMullen MR, Roychowdhury S, Pisano SG, Liu X, Stavitsky AB, et al. Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis. Hepatology 2013;57:1980–1991PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Hill DB, D’Souza NB, Lee EY, Burikhanov R, Deaciuc IV, de Villiers WJ. A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 2002;26:74–82PubMedCrossRefGoogle Scholar
  49. 49.
    Petrasek J, Dolganiuc A, Csak T, Nath B, Hritz I, Kodys K, et al. Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells. Hepatology 2011;53:649–660PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Kong X, Feng D, Mathews S, Gao B. Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease. J Gastroenterol Hepatol 2013;28(Suppl 1):56–60PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Asian Pacific Association for the Study of the Liver 2014

Authors and Affiliations

  1. 1.Department of MedicineUniversity of Massachusetts Medical SchoolWorcesterUSA
  2. 2.Department of MedicineUniversity of Massachusetts Medical SchoolWorcesterUSA

Personalised recommendations